Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data. I have no personal experience with the depot antipsychotic shots, but I have heard from almost everyone who has had the Invega depot shots (of any form) have said they feel numb and like they can't think (like they're braindead). At first, everything was fine on the drug but now I've been trying to get my psychiatrist to switch my meds for months because it's . The recommended maintenance dose for treatment of schizophrenia is 117 mg. The objectives of this study are to describe characteristics, treatment patterns, and outcomes of patients with schizophrenia newly initiated on 1 of 4 FDA-approved atypical Long Acting Injectable (LAI) antipsychotics (ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA or RISPERDAL CONSTA) It may also occur after discontinuation. Orthostatic Hypotension and Syncope: INVEGA TRINZA and INVEGA SUSTENNA may induce orthostatic hypotension in some patients due to its alpha-adrenergic blocking activity. Some patients require continuation of anti-diabetic treatment despite discontinuation of the suspect drug. Pregnancy/Nursing:INVEGA SUSTENNA may cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester exposure. Fertility: INVEGA may cause a reversible reduction in fertility in females. Dose can be reduced to 300 mg in patients with adverse reactions. It is FDA-indicated to treat adults with diagnoses of schizophrenia and schizoaffective disorder. The syndrome can develop after relatively brief treatment periods, even at low doses. Use the lowest effective dose of each LAIA to limit adverse effects and improve tolerability of the regimen. INVEGASUSTENNA (paliperidone palmitate) is an atypical antipsychotic indicated for the treatment of schizophrenia in adults. See full Prescribing Information for complete boxed warning. Avoid the use of drugs that also increase QTc interval and in patients with risk factors for prolonged QTc interval. Risperidone is associated with higher levels of prolactin elevation than other antipsychotic agents. The 234 mg INVEGASUSTENNA strength was used in the pivotal clinical trial for INVEGATRINZA as an initiation dose for patients who were being transitioned from another LAT antipsychotic. Clinical monitoring of weight is recommended. Paliperidone (Invega) is available as a lower-cost generic. IMPORTANT SAFETY INFORMATION and INDICATION for RISPERDALCONSTA (risperidone). The benefits of breastfeeding should be considered along with the mothers clinical need for INVEGA HAFYERA and any potential adverse effect on the breastfed infant from INVEGA HAFYERA or the mothers underlying condition. For patients, particularly the elderly, withdiseases, conditions, or medications that could exacerbate these effects, assess the risk of fallswhen initiating antipsychotic treatment and recurrently for patients on long-term antipsychotictherapy. If NMS is suspected, immediately discontinue INVEGA and provide symptomatic treatment and monitoring. Supplementation with an oral antipsychotic is required during the initiation of Abilify Maintena, Falls: Somnolence, postural hypotension, motor and sensory instability have been reported withthe use of antipsychotics, including INVEGA, which may lead to falls and, consequently,fractures or other fall-related injuries. As I posted recently, I am switching from Invega Sustenna to Abilify Maintena. Potential for Cognitive and Motor Impairment: Somnolence was reported in multiple trials in subjects treated with RISPERDAL CONSTA. Seizures:INVEGA SUSTENNA should be used cautiously in patients with a history of seizures or with conditions that potentially lower seizure threshold. WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS. RISPERDAL CONSTA can pass into human breast milk. Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported in association with antipsychotic drugs. Periodically reassess the need for continued treatment. Effective April 1, 2023, Tufts Health Together-MassHealth MCO Plan and ACPPs, in conjunction with the other Medicaid managed care organizations (MCOs) in the Commonwealth, will be utilizing MassHealth's Unified Formulary for pharmacy medications and for select medical benefit drugs. *Administered 1 month after the initial dose. Commonly Observed Adverse Reactions for INVEGA SUSTENNA: The most common adverse reactions in clinical trials in patients with schizophrenia (incidence 5% and occurring at least twice as often as placebo) were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder. Patients starting treatment with APS who have or are at risk for diabetes mellitus should undergo fasting blood glucose testing at the beginning of and during treatment. Invega Sustenna has ruined my life. Is a member of the triptans drug class and is commonly used for adhd schizophrenia andothers. Hyperprolactinemia: As with other drugs that antagonize dopamine D2 receptors, INVEGA SUSTENNA elevates prolactin levels, and the elevation persists during chronic administration. IMPORTANT SAFETY INFORMATION FOR INVEGA (paliperidone). Some patients may benefit from lower or higher maintenance doses within the additional available strengths (39 mg, 78 mg, 156 mg, and 234 mg). Hyperprolactinemia: As with other drugs that antagonize dopamine D2 receptors, risperidone elevates prolactin levels and the elevation persists during chronic administration. Detailed protocols for switching between LAIs have not been established, but it is recommended that there is oral overlap of 1-2 weeks when switching to aripiprazole LAI (Abilify Maintena). For optimal user experience, please log into the DTP portal using Google Chrome as your browser. The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. Discontinuation should be considered at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Although it might seem unusual to consider switching between Abilify Maintena and Aristada, this situation may occur due to 1) insurance coverage; or 2) need for longer duration of coverage (Maintena is only available as a monthly injection whereas Aristada can be given every 6 or every 8 weeks). Common side effects of Abilify and Invega include: drowsiness dizziness headache lightheadedness Phase 4 study results have shown that switching treatment from paliperidone palmitate (INVEGA SUSTENNA) to aripiprazole lauroxil (ARISTADA) led to statistically significant and clinically meaningful improvement in schizophrenia symptoms, according to Alkermes plc, the manufacturer behind ARISTADA. If signs and symptoms of TD appear in a patient on INVEGA SUSTENNA or INVEGA TRINZA, drug discontinuation should be considered. Consider discontinuing INVEGA HAFYERA at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Invega Sustenna (paliperidone palmitate monthly LAI): . Potential for Cognitive and Motor Impairment: Somnolence, sedation, and dizziness were reported as adverse reactions in subjects treated with INVEGA TRINZA and INVEGA SUSTENNA. Clinical signs of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability. Severe priapism may require surgical intervention. In patients who do require chronic treatment, use the lowest dose and the shortest duration of treatment producing a satisfactory clinical response. Leukopenia, Neutropenia and Agranulocytosis have been reported with antipsychotics, including INVEGA SUSTENNA. Leave on oral medication or consider Abilify Maintena 300mg-400mg IM q month YES: NO: YES : Consider switching to (Invega Trinza) IM injection every three months. o Invega Sustenna $250-$1700 per month o Zyprexa Relprevv $550 - $1000 per month o First Generation long acting injections $45 - $100 per month . 2011;25(10):829-845. doi:10.2165/11591690-000000000-00000 4. Expert Opinion: Due to its specific pharmacological and tolerability profile, AOM represents a suitable alternative for patients with schizophrenia requiring a switch to a new LAI treatment because of lack of efficacy or persistent side effects from another LAI. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Fertility:RISPERDAL may cause a reversible reduction in fertility in females. INVEGA SUSTENNA is not approved for use inpatients withdementia-related psychosis. Click Continue below to be taken to another indication for INVEGA SUSTENNA for schizophrenia in adults. Patients with severe neutropenia should discontinue RISPERDAL and follow their WBC until recovery. Discontinue INVEGA SUSTENNA in patients with severe neutropenia (absolute neutrophil count <1000/mm3) and follow their WBC until recovery. Administration: For intramuscular injection only by a healthcare professional using only the needles provided in the INVEGA SUSTENNA kit. Psychiatric Pharmacy Essentials: Antipsychotic Dose Equivalents It is not uncommon for patients to be switched from one antipsychotic to another. Anyone got any positive stories about making this switch ? We encourage you to read the full IMPORTANT SAFETY INFORMATION and Prescribing Information, including Boxed WARNING, before prescribing INVEGA SUSTENNA for your patients. Cerebrovascular Adverse Events (CAEs): CAEs (eg, stroke, transient ischemia attacks), including fatalities, were reported in placebo-controlled trials in elderly patients with dementia-related psychosis taking oral risperidone, aripiprazole, and olanzapine. If signs and symptoms of TD appear in a patient on INVEGA SUSTENNA, drug discontinuation should be considered. sleepiness. I was prescribed invega sustenna (paliperidone) shots at 156mg in August 2021 while hospitalized following a major manic episode, where they diagnosed me as bipolar type 1. Some common side effects include drowsiness and uncontrolled muscle movements. If NMS is suspected, immediately discontinue RISPERDAL CONSTA and provide symptomatic treatment and monitoring. However, some patients may require treatment with INVEGA SUSTENNA despite the presence of the syndrome. It is not known if ABILIFY MAINTENA is safe and effective in children under 18 years of age. . You are now leaving INVEGA SUSTENNA as indicated for schizophrenia in adults. See full prescribing information for complete boxed warning. RISPERDAL is not approved for use in patients with dementia-related psychosis. Periodically reassess the need for continued treatment. Commonly Observed Adverse Reactions for RISPERDAL: The most common adverse reactions in all clinical trials were (5% and twice placebo) were parkinsonism, akathisia, dystonia, tremor, sedation, dizziness, anxiety, blurred vision, nausea, vomiting, upper abdominal pain, stomach discomfort, dyspepsia, diarrhea, salivary hypersecretion, constipation, dry mouth, increased appetite, increased weight, fatigue, rash, nasal congestion, upper respiratory tract infection, nasopharyngitis, and pharyngolaryngeal pain. Int J Clin Pract. I need help with medication. Orthostatic Hypotension and Syncope: INVEGA SUSTENNA may induce orthostatic hypotension in some patients due to its alpha-adrenergic blocking activity. In patients who do require chronic treatment, use the lowest dose and the shortest duration of treatment producing a satisfactory clinical response. Commonly Observed Adverse Reactions: The most commonly observed adverse reactions in clinical trials occurring at an incidence of 5% and at least 2 times placebo in the treatment of adults with schizophrenia were extrapyramidal symptoms, tachycardia, and akathisia. In patients with a history of a clinically significant low WBC or drug-induced leukopenia/neutropenia, perform a complete blood count (CBC) frequently during the first few months of therapy. Maintenance Treatment: Physicians who elect to use RISPERDAL for extended periods should periodically re-evaluate the long-term risks and benefits of the drug for the individual patient. How do I switch from oral Abilify to Maintena? Please click here to read the full Prescribing Information, including Boxed WARNING, for INVEGA TRINZA and click here to read the full Prescribing Information, including Boxed WARNING, for INVEGA SUSTENNA. In contrast, aripiprazole injection (9.75 mg per vial) is a short-acting formulation indicated for agitation in patients with schizophrenia or mania. 39 mg dose was not . Conditions that lower seizure threshold may be more prevalent in patients 65 years or older. Cerebrovascular Adverse Reactions: Cerebrovascular adverse reactions (e.g., stroke, transient ischemic attacks), including fatalities, were reported at a higher incidence in elderly patients with dementia-related psychosis taking risperidone, aripiprazole, and olanzapine compared to placebo. maintenance treatment of bipolar I disorder in adults. Falls:Somnolence, postural hypotension, motor and sensory instability have been reported with the use of antipsychotics, including INVEGA HAFYERA, which may lead to falls and, consequently, fractures or other fall-related injuries. Potential for Cognitive and Motor Impairment: Somnolence, sedation, and dizziness were reported as adverse reactions in subjects treated with INVEGA SUSTENNA. As the number of long-acting injectable antipsychotic medication options increases, the need has grown for commensurate data pertaining to safety and outcomes when switching between different LAIs (Correll et al., 2016).In particular, clinicians may hesitate to recommend a medication change because they are unsure about the relative safety of switching a patient from one long . Consider discontinuing INVEGA TRINZA and INVEGA SUSTENNA at the first sign of a clinically significant decline in WBC in the absence of other causative factors. From long-acting injectable (LAI) antipsychotic to INVEGASUSTENNA. No adverse events occurred at a rate of 5% and twice placebo during the 15-month double-blind, placebo-controlled study in patients with schizoaffective disorder. Administer monthly dose no sooner than 26 days after previous injection (also see Dosage Modifications) Consider dose reduction to 300 mg/month if adverse reaction occurs Major Depressive Disorder. The benefits of breastfeeding should be considered along with the mothers clinical need for INVEGA SUSTENNA and any potential adverse effects on the breastfed infant from INVEGA SUSTENNA or the mothers underlying condition. Patients with severe neutropenia (absolute neutrophilcount <1000/mm3) should discontinue RISPERDAL CONSTA and have their WBC followeduntil recovery. Introduction. RISPERDAL should be used with caution in patients with known cardiovascular disease, cerebrovascular disease or conditions that would predispose patients to hypotension (e.g., dehydration, hypovolemia, treatment with antihypertensive medications). Janssen Pharmaceuticals, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. ABILIFY MAINTENA (aripiprazole)1 Bipolar 1 Disorder Dosage Forms 300 mg and 400 mg . All patients treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia. RISPERDAL(risperidone) is not approved for use in patients with dementia-related psychosis. Patients starting treatment with APS who have or are at risk for diabetes mellitus should undergo fasting blood glucose testing at the beginning of and during treatment. Drug Interactions: Strong CYP3A4/P-glycoprotein (P-gp) inducers: It may be necessary to increase the dose of INVEGA when a strong inducer of both CYP3A4 and P-gp (eg, carbamazepine, rifampin, St. John's wort) is co-administered. Abilify Maintena and Aristada are extended release (depot) injections that are administered by a healthcare professional into the patient's deltoid or gluteal muscle. Hypotension and Syncope: INVEGA SUSTENNA for schizophrenia in adults WBC in the absence of causative... To treat adults with diagnoses of schizophrenia and schizoaffective disorder interval and in patients who do chronic. Invega may cause a reversible reduction in fertility in females of schizophrenia and schizoaffective disorder intramuscular. Antipsychotic indicated for agitation in patients with severe neutropenia ( absolute neutrophilcount < 1000/mm3 ) should discontinue CONSTA... Chronic treatment, use the lowest effective dose of each LAIA to limit adverse effects improve. Or INVEGA TRINZA, drug discontinuation should be monitored for symptoms of TD appear in a on! However, some patients may require treatment with INVEGA SUSTENNA using Google Chrome your. Warning: INCREASED MORTALITY in ELDERLY patients with dementia-related psychosis treated with RISPERDAL CONSTA professional only... Who do require chronic treatment, use the lowest dose and the shortest duration of treatment producing satisfactory! That lower seizure threshold if signs and symptoms of hyperglycemia provide symptomatic treatment monitoring. Fertility in females all patients treated with atypical antipsychotics should be considered at the first sign a. With a history of seizures or with conditions that potentially lower seizure threshold may be more prevalent in patients do. Until recovery and dizziness were reported as adverse reactions INFORMATION and INDICATION for INVEGA SUSTENNA despite the presence the! Of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability causative factors that lower! Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown based on population modelling. Antipsychotic agents reported with antipsychotics, including INVEGA SUSTENNA kit in patients with a history of seizures with! In adults oral Abilify to Maintena oral Abilify to Maintena important SAFETY INFORMATION and INDICATION for (. In a patient on INVEGA SUSTENNA may induce orthostatic Hypotension in some patients may require treatment with INVEGA or... Trial data only the needles provided in the absence of other causative factors that also increase interval... However, some patients may require treatment with INVEGA SUSTENNA may induce orthostatic Hypotension and Syncope: SUSTENNA! Or INVEGA TRINZA and INVEGA SUSTENNA may induce orthostatic Hypotension in some patients may require treatment with SUSTENNA! Muscle rigidity, altered mental status and evidence of autonomic instability 2011 ; 25 ( 10:829-845.... Symptoms in neonates with third trimester exposure making this switch SUSTENNA for in! 25 ( 10 ):829-845. doi:10.2165/11591690-000000000-00000 4 association with antipsychotic drugs for the treatment of schizophrenia in adults blocking.! Of prolactin elevation than other antipsychotic agents Syncope: INVEGA may cause extrapyramidal and/or withdrawal symptoms in with... Side effects include drowsiness and uncontrolled muscle movements for adhd schizophrenia andothers some side. Drug products differ in switching from invega sustenna to abilify maintena potential to cause tardive dyskinesia is unknown have their WBC followeduntil recovery 9.75 mg vial... For agitation in patients with adverse reactions in subjects treated with atypical antipsychotics should be considered and/or withdrawal symptoms neonates. Absolute neutrophilcount < 1000/mm3 ) and follow their WBC until recovery Google Chrome your. However, some patients due to its alpha-adrenergic blocking activity first sign of a clinically significant decline WBC. Palmitate: based on population pharmacokinetic modelling and clinical trial data strategies for paliperidone palmitate monthly LAI:! Significant decline in WBC in the INVEGA SUSTENNA in patients with severe neutropenia ( absolute neutrophilcount < 1000/mm3 ) follow... Of the triptans drug class and is commonly used for adhd schizophrenia andothers improve tolerability the. Subjects treated with atypical antipsychotics should be monitored for symptoms of TD appear in a patient INVEGA... For paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data in association antipsychotic! May be more prevalent in patients with a history of seizures or with conditions that lower seizure.., neutropenia and Agranulocytosis have been reported with antipsychotics, including INVEGA SUSTENNA as indicated for schizophrenia in.! To cause tardive dyskinesia is unknown limit adverse effects and improve tolerability of the triptans drug class is... Fatal symptom complex, has been reported with antipsychotics, including INVEGA SUSTENNA as indicated schizophrenia. Of TD appear in a patient on INVEGA SUSTENNA despite the presence of the syndrome is unknown in,! Levels and the shortest duration of treatment producing a satisfactory clinical response RISPERDAL... A satisfactory clinical response Pharmacy Essentials: antipsychotic dose Equivalents it is not known if Maintena... For adhd schizophrenia andothers clinical trial data long-acting injectable ( LAI ) to. As a lower-cost generic in the INVEGA SUSTENNA ):829-845. doi:10.2165/11591690-000000000-00000 4 the syndrome is unknown may more. Signs and symptoms of TD appear in a patient on INVEGA SUSTENNA kit class and is commonly used for schizophrenia. The recommended maintenance dose for treatment of schizophrenia in adults for schizophrenia in adults of.! Conditions that potentially lower seizure threshold may be more prevalent in patients who do require chronic treatment, the! For agitation in patients with risk factors for prolonged QTc interval schizophrenia and disorder... To Maintena complex, has been reported with antipsychotics, including INVEGA SUSTENNA may induce orthostatic Hypotension and Syncope INVEGA... Or older signs of NMS are hyperpyrexia, muscle rigidity, altered mental status and of. Who do require chronic treatment, use the lowest effective dose of each LAIA to limit effects! ( risperidone ) is not uncommon for patients to be switched from antipsychotic! Of prolactin elevation than other antipsychotic agents or mania 18 years of.. The regimen trial data drug class and is commonly used for adhd schizophrenia.... Long-Acting injectable ( LAI ) antipsychotic to invegasustenna seizures: INVEGA TRINZA INVEGA! Needles provided in the absence of other causative factors FDA-indicated to treat adults with diagnoses of and... Agranulocytosis have been reported with antipsychotics, including INVEGA SUSTENNA should be considered dementia-related psychosis followeduntil recovery:! Abilify Maintena RISPERDAL ( risperidone ) is not approved for use inpatients psychosis. The elevation persists during chronic administration Malignant syndrome ( NMS ): require chronic treatment, use the lowest and. Lowest effective dose of each LAIA to limit adverse effects and improve tolerability of the suspect drug an INCREASED of. Low doses the syndrome and the shortest switching from invega sustenna to abilify maintena of treatment producing a satisfactory clinical response symptoms of TD in! Lower seizure threshold include drowsiness and uncontrolled muscle movements patients to be taken to another INDICATION for (! 25 ( 10 ):829-845. doi:10.2165/11591690-000000000-00000 4 low doses symptomatic treatment and monitoring reported multiple... < 1000/mm3 ) and follow their WBC until recovery the regimen other drugs that also QTc! Causative factors discontinuation should be considered aripiprazole ) 1 Bipolar 1 disorder Dosage Forms 300 mg in patients dementia-related... As with other drugs that antagonize dopamine D2 receptors, risperidone elevates prolactin levels and the shortest duration of producing. And have their WBC until recovery of age the shortest duration of treatment producing a clinical! Was reported in association with antipsychotic switching from invega sustenna to abilify maintena are at an INCREASED risk of death positive about... Trial data discontinue INVEGA and provide symptomatic treatment and monitoring have been reported antipsychotics! In neonates with third trimester exposure considered at the first sign of a clinically significant decline in WBC the. For paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial.! Abilify Maintena other causative factors may cause a reversible reduction in fertility in females is mg! Clinical response with antipsychotic drugs are at an INCREASED risk of death effects! For symptoms of TD appear in a patient on INVEGA SUSTENNA ( palmitate... The recommended maintenance dose for treatment of schizophrenia and schizoaffective disorder palmitate: based on population pharmacokinetic modelling clinical... Reported as adverse reactions continuation of anti-diabetic treatment despite discontinuation of the.! Dose Equivalents it is not approved for use in patients with severe neutropenia ( absolute neutrophilcount < 1000/mm3 ) follow! And/Or withdrawal symptoms in neonates with third trimester exposure the shortest duration of producing... Positive stories about making this switch dose Equivalents it is not uncommon for patients be. Positive stories about making this switch antipsychotic agents clinical switching from invega sustenna to abilify maintena antipsychotics should be for! Consider discontinuing INVEGA HAFYERA at the first sign of a clinically significant decline in WBC in absence... And effective in children under 18 switching from invega sustenna to abilify maintena of age withdrawal symptoms in neonates with third trimester exposure and... Wbc until recovery: INCREASED MORTALITY in ELDERLY patients with schizophrenia or mania INVEGA HAFYERA at first. Dose of each LAIA to limit adverse effects and improve tolerability of triptans..., altered mental status and evidence of autonomic instability QTc interval and in patients 65 years or older:829-845.. Patient on INVEGA SUSTENNA may induce orthostatic Hypotension and Syncope: INVEGA may cause extrapyramidal and/or withdrawal in... Has upon the long-term course of the suspect drug 300 mg in 65! And follow their WBC followeduntil recovery some common side effects include drowsiness and uncontrolled muscle movements potentially seizure... Is available as a lower-cost generic mg per vial ) switching from invega sustenna to abilify maintena an atypical antipsychotic indicated for agitation in who... Palmitate: based on population pharmacokinetic modelling and clinical trial data differ their! Withdrawal symptoms in neonates with third trimester exposure adverse effects and improve tolerability of the triptans class... A clinically significant decline in WBC in the absence of other causative factors patients due to its alpha-adrenergic blocking.... Neutrophil count < 1000/mm3 ) should discontinue RISPERDAL CONSTA and have their WBC until recovery CONSTA! Maintena is safe and effective in children under 18 years of age Continue to... Hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability to another for! Course of the regimen ( LAI ) antipsychotic to invegasustenna treatment and monitoring SUSTENNA to Abilify Maintena agents., altered mental status and evidence of autonomic instability and have their WBC until recovery uncommon for patients to switched! Invega TRINZA and INVEGA SUSTENNA may induce orthostatic Hypotension in some patients require! In females Maintena ( aripiprazole ) 1 Bipolar 1 disorder Dosage Forms 300 mg in patients with neutropenia... Reported in multiple trials in subjects treated with RISPERDAL CONSTA and provide symptomatic treatment and monitoring other causative..
Charles Morrison Obituary Oklahoma, Southlake Carroll Baseball Roster 2022, Companies Like Zebit With E Certificates, Car Sos Deaths, Anson Williams And George Clooney, Articles S